Enzon Pharmaceuticals, Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced total revenue was USD 291,000 compared to USD 8,000 a year ago. Operating loss was USD 21,000 compared to USD 236,000 a year ago. Net loss was USD 19,000 compared to USD 236,000 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago. For the half year, total revenue was USD 672,000 compared to USD 10,000 a year ago. Operating loss was USD 10,000 compared to USD 476,000 a year ago. Net loss was USD 8,000 compared to USD 478,000 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.